DocGo Inc. (NASDAQ:DCGO) Receives $3.21 Average PT from Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO) have received a consensus recommendation of “Hold” from the seven brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $3.2125.

Several research firms recently issued reports on DCGO. Weiss Ratings reissued a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Canaccord Genuity Group lowered their target price on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Finally, Zacks Research raised shares of DocGo from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th.

DocGo Stock Performance

Shares of DCGO stock opened at $0.84 on Monday. The stock has a market capitalization of $82.17 million, a price-to-earnings ratio of -1.62 and a beta of 0.94. DocGo has a one year low of $0.81 and a one year high of $5.68. The company’s 50-day simple moving average is $0.93 and its 200-day simple moving average is $1.23.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Monday, November 10th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.02). DocGo had a negative net margin of 14.02% and a negative return on equity of 9.11%. The firm had revenue of $70.81 million during the quarter, compared to the consensus estimate of $69.96 million. As a group, research analysts forecast that DocGo will post 0.25 EPS for the current year.

Hedge Funds Weigh In On DocGo

A number of large investors have recently bought and sold shares of the business. Bridgeway Capital Management LLC raised its position in DocGo by 3.6% in the third quarter. Bridgeway Capital Management LLC now owns 370,699 shares of the company’s stock worth $504,000 after acquiring an additional 12,942 shares in the last quarter. Jane Street Group LLC boosted its position in shares of DocGo by 18.8% during the 1st quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock valued at $226,000 after purchasing an additional 13,505 shares in the last quarter. CWM LLC grew its stake in shares of DocGo by 2,613.3% in the 2nd quarter. CWM LLC now owns 21,978 shares of the company’s stock worth $35,000 after purchasing an additional 21,168 shares during the last quarter. Cerity Partners LLC bought a new stake in shares of DocGo in the 2nd quarter worth approximately $37,000. Finally, Strs Ohio bought a new stake in shares of DocGo in the 1st quarter worth approximately $76,000. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.